Scopus BioPharma Inc (SCPS)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Scopus BioPharma Cash from Financing (Quarterly): -0.0447M for June 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.0447M |
| March 31, 2023 | 2.019M |
| December 31, 2022 | 0.2419M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 8.480M |
| September 30, 2021 | -0.1045M |
| June 30, 2021 | -0.0191M |
| March 31, 2021 | 9.200M |
| Date | Value |
|---|---|
| December 31, 2020 | 2.361M |
| September 30, 2020 | 0.3318M |
| June 30, 2020 | 1.579M |
| March 31, 2020 | 0.0808M |
| December 31, 2019 | -0.003M |
| September 30, 2019 | 0.3922M |
| June 30, 2019 | 0.9595M |
| March 31, 2019 | 0.835M |
| June 30, 2018 | -0.0005M |
| March 31, 2018 | 0.1832M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.1045M
Minimum
Sep 2021
9.200M
Maximum
Mar 2021
1.498M
Average
0.2419M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| FluoroPharma Medical Inc | 0.1135M |
| RenovaCare Inc | 0.00 |
| Xeno Transplants Corp | -- |
| Entia Biosciences Inc | 0.514M |
| Regenerx Biopharmaceuticals Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.009M |
| Free Cash Flow | -3.043M |
| Free Cash Flow Per Share (Quarterly) | -0.0254 |